The 13 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 11.00, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +22.97% increase from the last price of 8.95.
The current consensus among 17 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.65
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.